Aim: The study aims to evaluate the anti-angiogenic and cytotoxic properties of Carissa carandas Linn., a medicinal plant traditionally used in India for various ailments.
Method: The plant's leaf extracts were prepared using methanol and n-hexane solvents and subjected to phytochemical analysis, revealing the presence of compounds like tannins, triterpenoids, and flavonoids. The antioxidant potential of the extracts was assessed, with the fruit extract showing remarkable scavenging activity against free radicals. The anti-angiogenic activity was examined using the Chorioallantoic Membrane (CAM) assay. Cytotoxicity was determined through the Brine Shrimp Lethality Assay (BSL.
Results: The Chorioallantoic Membrane (CAM) assay demonstrated significant inhibition of blood vessel formation by the plant extracts. Cytotoxicity assays indicated that both methanol and n-hexane extracts contain potent bioactive constituents, albeit less potent than the standard potassium dichromate.
Conclusion: The findings suggest that Carissa carandas Linn. possesses significant anti-angiogenic and cytotoxic properties, supporting its traditional use in medicine and highlighting its potential as a source of novel anticancer compounds. The study underscores the importance of scientific validation of medicinal plants' therapeutic properties and contributes to the growing interest in natural products for cancer treatment.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
